avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Yy2 | mm10_v2_chrX_-_157598642_157598655 | -0.41 | 1.2e-02 | Click! |
Yy1 | mm10_v2_chr12_+_108792946_108792988 | -0.26 | 1.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_69284982 Show fit | 9.10 |
ENSMUST00000183882.1
ENSMUST00000037064.4 |
solute carrier family 25, member 37 |
|
chr5_-_134915512 Show fit | 8.03 |
ENSMUST00000008987.4
|
claudin 13 |
|
chr13_-_21753851 Show fit | 7.22 |
ENSMUST00000074752.2
|
histone cluster 1, H2ak |
|
chr13_-_23551648 Show fit | 6.74 |
ENSMUST00000102971.1
|
histone cluster 1, H4f |
|
chr8_-_121907678 Show fit | 6.42 |
ENSMUST00000045557.9
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
|
chr4_-_46404224 Show fit | 5.97 |
ENSMUST00000107764.2
|
hemogen |
|
chr11_+_117849286 Show fit | 5.55 |
ENSMUST00000093906.4
|
baculoviral IAP repeat-containing 5 |
|
chr15_-_103252810 Show fit | 5.52 |
ENSMUST00000154510.1
|
nuclear factor, erythroid derived 2 |
|
chr10_+_43579161 Show fit | 5.51 |
ENSMUST00000058714.8
|
CD24a antigen |
|
chr7_-_103843154 Show fit | 5.49 |
ENSMUST00000063957.4
|
hemoglobin Z, beta-like embryonic chain |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 46.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 32.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 23.0 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.8 | 19.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 17.6 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.4 | 14.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
2.2 | 13.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 12.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.8 | 11.9 | GO:0015816 | glycine transport(GO:0015816) |
0.9 | 11.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 75.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.9 | 45.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.2 | 45.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 27.6 | GO:0000786 | nucleosome(GO:0000786) |
2.7 | 21.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 15.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 13.6 | GO:0044391 | ribosomal subunit(GO:0044391) |
2.3 | 13.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 10.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 9.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 117.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.6 | 32.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 20.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 17.8 | GO:0050699 | WW domain binding(GO:0050699) |
3.4 | 13.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.3 | 11.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.5 | 11.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.8 | 11.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 11.6 | GO:0004519 | endonuclease activity(GO:0004519) |
1.9 | 11.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 26.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 20.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 18.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 14.5 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 13.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 10.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 9.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 9.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 8.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 7.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 126.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.2 | 64.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 21.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 20.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 16.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.6 | 14.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 13.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.3 | 12.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.6 | 11.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 10.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |